SYNLOGIC, INC. Investment Income, Interest
SYNLOGIC, INC. (SYBX) reported Investment Income, Interest of $95.00 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-04.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2017-08-04
- SYNLOGIC, INC. investment income, interest for the quarter ending 2017-06-30 was $95.00K, a 2.15% increase year-over-year.
- SYNLOGIC, INC. investment income, interest for the quarter ending 2017-03-31 was $86.00K, a 4.88% increase year-over-year.
- SYNLOGIC, INC. investment income, interest for the quarter ending 2016-12-31 was $78.00K, a 116.67% increase year-over-year.
- SYNLOGIC, INC. investment income, interest for the quarter ending 2016-09-30 was $97.00K, a 1112.50% increase year-over-year.
- SYNLOGIC, INC. investment income, interest for fiscal 2016 was $350.00K, a 695.45% increase from fiscal 2015.
- SYNLOGIC, INC. investment income, interest for fiscal 2015 was $44.00K.
- SYNLOGIC, INC. investment income, interest for fiscal 2014 was $0.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2017-06-30 | $95.00K 10-Q · filed 2017-08-04 | $182.00K 10-Q · filed 2017-08-04 | $259.00K derived: sum of 3 quarters · filed 2017-08-04 | $356.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2017-03-31 | $86.00K 10-Q · filed 2017-05-09 | $164.00K derived: sum of 2 quarters · filed 2017-05-09 | $261.00K derived: sum of 3 quarters · filed 2017-05-09 | $354.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $175.00K derived: sum of 2 quarters · filed 2017-03-15 | $268.00K derived: sum of 3 quarters · filed 2017-08-04 | $350.00K 10-K · filed 2017-03-15 |
| 2016-09-30 | $97.00K 10-Q · filed 2016-11-10 | $190.00K derived: sum of 2 quarters · filed 2017-08-04 | $272.00K 10-Q · filed 2016-11-10 | $308.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-06-30 | $93.00K 10-Q · filed 2017-08-04 | $175.00K 10-Q · filed 2017-08-04 | $211.00K derived: sum of 3 quarters · filed 2017-08-04 | $219.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | $82.00K 10-Q · filed 2017-05-09 | $118.00K derived: sum of 2 quarters · filed 2017-05-09 | $126.00K derived: sum of 3 quarters · filed 2017-05-09 | |
| 2015-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $44.00K derived: sum of 2 quarters · filed 2017-03-15 | $44.00K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $8.00K 10-Q · filed 2016-11-10 | $8.00K 10-Q · filed 2016-11-10 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |